CFS
NVO

CGC Financial Services’s Novo Nordisk NVO Stock Holding History

CGC Financial Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60
Closed -$3.05K – 352
2025
Q4 		$3.05K Sell
60
-5
-8% -$256 ﹤0.01% 282
2025
Q3 		$3.61K Hold
65
– – ﹤0.01% 275
2025
Q2 		$4.49K Hold
65
– – ﹤0.01% 256
2025
Q1 		$4.51K Hold
65
– – ﹤0.01% 244
2024
Q4 		$5.59K Hold
65
– – ﹤0.01% 239
2024
Q3 		$7.74K Hold
65
– – ﹤0.01% 216
2024
Q2 		$9.28K Hold
65
– – ﹤0.01% 204
2024
Q1 		$8.35K Buy
65
+5
+8% +$595 ﹤0.01% 220
2023
Q4 		$6.21K Buy
+60
New +$5.93K ﹤0.01% 248

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

CGC Financial Services's NVO Position: Q1 2026 in Review

CGC Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 60 shares — an estimated $3.05K sold.

CGC Financial Services first reported a position in NVO in Q4 2023 and held it in 9 quarters. The position peaked at $9.28K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • CGC Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • CGC Financial Services sold 60 Novo Nordisk shares in Q1 2026, an estimated $3.05K.
  • CGC Financial Services first reported a position in Novo Nordisk in Q4 2023 and held it in 9 quarters.
  • CGC Financial Services's Novo Nordisk position peaked at $9.28K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on CGC Financial Services's 13F filing for Q1 2026, filed 14 Apr 2026.